Literature DB >> 25708577

Prostate cancer: Breaking AKR1C3-mediated enzalutamide resistance by inhibiting androgen synthesis.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25708577     DOI： 10.1038/nrurol.2015.31

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer.

Authors:  Chengfei Liu; Wei Lou; Yezi Zhu; Joy C Yang; Nagalakshmi Nadiminty; Nilesh W Gaikwad; Christopher P Evans; Allen C Gao
Journal:  Cancer Res       Date:  2015-02-03       Impact factor: 12.701
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.